Paper39296276
The Ubiquitin Tale: Current Strategies and Future Challenges.
Upadhyay A and 1 other. ACS Pharmacol Transl Sci, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. The Ubiquitin Tale: Current Strategies and Future Challenges. Papers, record 39296276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39296276
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References169
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19325621 | Origin and function of ubiquitin-like proteins. | Nature | 2009 | https://conductscience.org/library/papers/19325621 | PubMed |
| 2 | 33402098 | Beyond K48 and K63: non-canonical protein ubiquitination. | Cell Mol Biol Lett | 2021 | https://conductscience.org/library/papers/33402098 | PubMed |
| 3 | 20811356 | Selective autophagy: ubiquitin-mediated recognition and beyond. | Nat Cell Biol | 2010 | https://conductscience.org/library/papers/20811356 | PubMed |
| 4 | 1482093 | Protein synthesis, posttranslational modifications, and aging. | Ann N Y Acad Sci | 1992 | https://conductscience.org/library/papers/1482093 | PubMed |
| 5 | 33826699 | Posttranslational modifications in proteins: resources, tools and prediction methods. | Database (Oxford) | 2021 | https://conductscience.org/library/papers/33826699 | PubMed |
| 6 | 16601694 | Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. | EMBO J | 2006 | https://conductscience.org/library/papers/16601694 | PubMed |
| 7 | 19185524 | Structural basis for recognition of diubiquitins by NEMO. | Mol Cell | 2009 | https://conductscience.org/library/papers/19185524 | PubMed |
| 8 | 21867568 | Atg8: an autophagy-related ubiquitin-like protein family. | Genome Biol | 2011 | https://conductscience.org/library/papers/21867568 | PubMed |
| 9 | 25060092 | Met1-linked ubiquitination in immune signalling. | FEBS J | 2014 | https://conductscience.org/library/papers/25060092 | PubMed |
| 10 | 20153823 | ISG15 and immune diseases. | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/20153823 | PubMed |
| 11 | 16413479 | Lingering mysteries of ubiquitin-chain assembly. | Cell | 2006 | https://conductscience.org/library/papers/16413479 | PubMed |
| 12 | 14625536 | Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. | Nat Rev Mol Cell Biol | 2003 | https://conductscience.org/library/papers/14625536 | PubMed |
| 13 | 19633314 | Stressing the ubiquitin-proteasome system. | Cardiovasc Res | 2010 | https://conductscience.org/library/papers/19633314 | PubMed |
| 14 | 21151032 | Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. | Nat Rev Drug Discov | 2011 | https://conductscience.org/library/papers/21151032 | PubMed |
| 15 | 21102611 | The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. | Nat Rev Mol Cell Biol | 2010 | https://conductscience.org/library/papers/21102611 | PubMed |
| 16 | 16335966 | Proteomic analysis of ubiquitinated proteins from human MCF-7 breast cancer cells by immunoaffinity purification and mass spectrometry. | J Proteome Res | 2005 | https://conductscience.org/library/papers/16335966 | PubMed |
| 17 | 19253967 | Functional roles of ubiquitin-like domain (ULD) and ubiquitin-binding domain (UBD) containing proteins. | Chem Rev | 2009 | https://conductscience.org/library/papers/19253967 | PubMed |
| 18 | 33441937 | Met1-linked ubiquitin signalling in health and disease: inflammation, immunity, cancer, and beyond. | Cell Death Differ | 2021 | https://conductscience.org/library/papers/33441937 | PubMed |
| 19 | 22390971 | Emerging role of ubiquitination in antiviral RIG-I signaling. | Microbiol Mol Biol Rev | 2012 | https://conductscience.org/library/papers/22390971 | PubMed |
| 20 | 2160452 | A uniform isopeptide-linked multiubiquitin chain is sufficient to target substrate for degradation in ubiquitin-mediated proteolysis. | J Biol Chem | 1990 | https://conductscience.org/library/papers/2160452 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942740 | Peptide-Based Molecular Glues for Targeted Protein Degradation. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942740 | PubMed |
| 42882418 | Decoding the Cellular Response to Methylthioadenosine Uncovers Novel Targets for Chronic Liver Disease. | Cells | 2026 | https://conductscience.org/library/papers/42882418 | PubMed |
| 42294954 | KCMF1-mediated influenza A virus PB1 ubiquitination at K653 regulates viral replication. | J Virol | 2026 | https://conductscience.org/library/papers/42294954 | PubMed |
| 42129581 | Decoding the Oncogenic Role of USP22 Through Pan-Cancer Genomic and Epigenetic Analysis. | Cancer Rep (Hoboken) | 2026 | https://conductscience.org/library/papers/42129581 | PubMed |
| 41619095 | Ubiquitination and deubiquitination as critical modulators of NSCLC tumorigenesis and drug resistance. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41619095 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39296276
GET https://conductscience.org/api/papers/v1/39296276/references?page=2